DK140667B - Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere former eller salte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere former eller salte deraf.

Info

Publication number
DK140667B
DK140667B DK53174AA DK53174A DK140667B DK 140667 B DK140667 B DK 140667B DK 53174A A DK53174A A DK 53174AA DK 53174 A DK53174 A DK 53174A DK 140667 B DK140667 B DK 140667B
Authority
DK
Denmark
Prior art keywords
dihydropteridines
salts
preparation
tautomeric forms
analogous process
Prior art date
Application number
DK53174AA
Other languages
Danish (da)
English (en)
Other versions
DK140667C (ja
Inventor
Hamish Christopher Swan Wood
Norman Whittaker
Irene Stirling
Kyuji Ohta
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB518673A external-priority patent/GB1468171A/en
Priority claimed from DK420173AA external-priority patent/DK138019B/da
Priority to AR252155A priority Critical patent/AR205702A1/es
Priority to ZA00740657A priority patent/ZA74657B/xx
Priority to BE140440A priority patent/BE810474A/xx
Priority to CS7400000661A priority patent/CS183731B2/cs
Priority to HU74WE00000499A priority patent/HU171384B/hu
Priority to NL7401350A priority patent/NL7401350A/xx
Priority to DE2404593A priority patent/DE2404593A1/de
Priority to CA191,502A priority patent/CA1025855A/en
Priority to IN208/CAL/74A priority patent/IN139181B/en
Priority to DK53174AA priority patent/DK140667B/da
Application filed by Wellcome Found filed Critical Wellcome Found
Priority to FI267/74A priority patent/FI55663C/fi
Priority to JP49013252A priority patent/JPS49102695A/ja
Priority to IE176/74A priority patent/IE38809B1/xx
Priority to PL1974168470A priority patent/PL91643B1/pl
Priority to SE7401254A priority patent/SE415563B/xx
Priority to CH136274A priority patent/CH601300A5/xx
Priority to ES422825A priority patent/ES422825A1/es
Priority to IL44123A priority patent/IL44123A/en
Priority to DD176300A priority patent/DD110499A5/xx
Priority to FR7403214A priority patent/FR2215963A1/fr
Priority to AU65134/74A priority patent/AU478874B2/en
Publication of DK140667B publication Critical patent/DK140667B/da
Publication of DK140667C publication Critical patent/DK140667C/da
Application granted granted Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D475/00—Heterocyclic compounds containing pteridine ring systems
    • C07D475/02—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4
    • C07D475/04—Heterocyclic compounds containing pteridine ring systems with an oxygen atom directly attached in position 4 with a nitrogen atom directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/63—Compounds containing para-N-benzenesulfonyl-N-groups, e.g. sulfanilamide, p-nitrobenzenesulfonyl hydrazide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK53174AA 1973-02-01 1974-01-31 Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere former eller salte deraf. DK140667B (da)

Priority Applications (21)

Application Number Priority Date Filing Date Title
AR252155A AR205702A1 (es) 1973-02-01 1974-01-01 Metodo para producir un nuevo derivado de 2-amino-4-hidroxi-7,8-dihidropteridina-6-carboxaldehido
FR7403214A FR2215963A1 (en) 1973-02-01 1974-01-31 Pteridine antimicrobials and bacteriostats
JP49013252A JPS49102695A (ja) 1973-02-01 1974-01-31
CS7400000661A CS183731B2 (en) 1973-02-01 1974-01-31 Method for producing novel pteridine derivatives
HU74WE00000499A HU171384B (hu) 1973-02-01 1974-01-31 Sposob poluchenija biologicheski aktivnykh proizvodnykh pteridina
NL7401350A NL7401350A (ja) 1973-02-01 1974-01-31
DE2404593A DE2404593A1 (de) 1973-02-01 1974-01-31 Biologisch wirksame verbindungen
CA191,502A CA1025855A (en) 1973-02-01 1974-01-31 Pteridine derivatives
IN208/CAL/74A IN139181B (ja) 1973-02-01 1974-01-31
DK53174AA DK140667B (da) 1973-02-01 1974-01-31 Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere former eller salte deraf.
ZA00740657A ZA74657B (en) 1973-02-01 1974-01-31 Biologically active compounds
FI267/74A FI55663C (fi) 1973-02-01 1974-01-31 Foerfarande foer framstaellning av antimikrobiskt verkande 2-amino-4-hydroxi-7,7-dimetyl-7,8-dihydropteridin-6-karboxialdehyd
BE140440A BE810474A (fr) 1973-02-01 1974-01-31 Composes a activite biologique
IE176/74A IE38809B1 (en) 1973-02-01 1974-01-31 "2-amino-4-hydroxy-7,8-dithydropteridine-6-carboxaldehyde derivatives
PL1974168470A PL91643B1 (ja) 1973-02-01 1974-01-31
SE7401254A SE415563B (sv) 1973-02-01 1974-01-31 Analogiforfarande for framstellning av 2-amino-4hydroxi-7,7-dimetyl-7,8-dihydropteridin-6-karboxaldehyd
CH136274A CH601300A5 (ja) 1973-02-01 1974-01-31
ES422825A ES422825A1 (es) 1973-02-01 1974-01-31 Un metodo de preparar derivados de pteridina.
IL44123A IL44123A (en) 1973-02-01 1974-01-31 2-amino-4-hydroxy-7,8-dihydropteridine-6-carboxaldehyde derivatives their preparation and pharmaceutical compositions containing them
DD176300A DD110499A5 (ja) 1973-02-01 1974-01-31
AU65134/74A AU478874B2 (en) 1973-02-01 1974-02-01 Biologically active compounds

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB518673A GB1468171A (en) 1973-02-01 1973-02-01 2-amino-4-hydroxy-7,8-dihydropteridine-6-carboxaldehyde deri vatives
DK420173AA DK138019B (da) 1972-08-01 1973-07-31 Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere eller salte deraf.
DK53174AA DK140667B (da) 1973-02-01 1974-01-31 Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere former eller salte deraf.

Publications (2)

Publication Number Publication Date
DK140667B true DK140667B (da) 1979-10-22
DK140667C DK140667C (ja) 1980-03-24

Family

ID=27220757

Family Applications (1)

Application Number Title Priority Date Filing Date
DK53174AA DK140667B (da) 1973-02-01 1974-01-31 Analogifremgangsmåde til fremstilling af 7,8-dihydropteridiner eller tautomere former eller salte deraf.

Country Status (20)

Country Link
JP (1) JPS49102695A (ja)
AR (1) AR205702A1 (ja)
BE (1) BE810474A (ja)
CA (1) CA1025855A (ja)
CH (1) CH601300A5 (ja)
CS (1) CS183731B2 (ja)
DD (1) DD110499A5 (ja)
DE (1) DE2404593A1 (ja)
DK (1) DK140667B (ja)
ES (1) ES422825A1 (ja)
FI (1) FI55663C (ja)
FR (1) FR2215963A1 (ja)
HU (1) HU171384B (ja)
IE (1) IE38809B1 (ja)
IL (1) IL44123A (ja)
IN (1) IN139181B (ja)
NL (1) NL7401350A (ja)
PL (1) PL91643B1 (ja)
SE (1) SE415563B (ja)
ZA (1) ZA74657B (ja)

Also Published As

Publication number Publication date
DD110499A5 (ja) 1974-12-20
ES422825A1 (es) 1976-05-01
IE38809L (en) 1974-08-01
FI55663B (fi) 1979-05-31
CH601300A5 (ja) 1978-07-14
CS183731B2 (en) 1978-07-31
PL91643B1 (ja) 1977-03-31
IL44123A0 (en) 1974-05-16
BE810474A (fr) 1974-07-31
CA1025855A (en) 1978-02-07
AR205702A1 (es) 1976-05-31
IE38809B1 (en) 1978-06-07
IL44123A (en) 1977-10-31
DK140667C (ja) 1980-03-24
DE2404593A1 (de) 1974-08-15
JPS49102695A (ja) 1974-09-27
AU6513474A (en) 1975-08-07
FR2215963B1 (ja) 1976-09-03
SE415563B (sv) 1980-10-13
FR2215963A1 (en) 1974-08-30
IN139181B (ja) 1976-05-15
NL7401350A (ja) 1974-08-05
ZA74657B (en) 1975-09-24
HU171384B (hu) 1977-12-28
FI55663C (fi) 1979-09-10

Similar Documents

Publication Publication Date Title
DK131725B (da) Analogifremgangsmåde til fremstilling af 2,4-diaminoquinazoliner eller salte deraf.
DK136718B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyran-9-oner.
DK136719B (da) Analogifremgangsmåde til fremstilling af substituerede hexahydro-dibenzo(b,d)-pyraner.
DK132172B (da) Analogifremgangsmåde til fremstilling af 6,7-benzomorphaner eller salte deraf.
DK140461B (da) Analogifremgangsmåde til fremstilling af 8-azapurin-6-oner eller salte deraf.
DK134490B (da) Analogifremgangsmåde til fremstilling af 2,6-diaminonebularin-derivater.
DK139678B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK136060B (da) Analogifremgangsmåde til fremstilling af 3-substituerede 1,4,5,6-tetrahydropyridiner eller salte deraf.
DK128078B (da) Analogifremgangsmåde til fremstilling af 1,2,3,4-tetrahydroisoquinolinderivater eller salte deraf.
DK138020B (da) Analogifremgangsmåde til fremstilling af pyrazolodiazepinforbindelser eller salte deraf.
DK140406B (da) Fremgangsmåde til fremstilling af 2,2,6,6-tetramethyl-4-oxopiperidin.
DK135683B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzyl-pyrimidinderivater eller salte af disse forbindelser.
DK136470B (da) Analogifremgangsmåde til fremstilling af 2,4-diamino-5-benzylpyrimidinderivater eller salte deraf.
DK136816B (da) Analogifremgangsmåde til fremstilling af phenoxypropylaminderivater eller af deres salte.
DK138797B (da) Analogifremgangsmåde til fremstilling af 1,4-benzodiazepin-derivater eller N-oxider eller salte deraf.
DK135723B (da) Analogifremgangsmåde til fremstilling af 7alfa-acylthio-3-oxo-D-homo-21,24-dinor-17aalfa-chlo-4-en-23,17a-lactoner.
DK138497B (da) Analogifremgangsmåde til fremstilling af 4-hydroxy-4-(3,4-methylen-dioxyphenyl)piperidiner eller salte deraf.
DK134233B (da) Analogifremgangsmåde til fremstilling af substituerede benzimidazolinoner eller triazaspiro-/4,5/-decan-4-oner eller syreadditionssalte deraf.
DK133979B (da) Analogifremgangsmåde til fremstilling af 5-methyl-10-(beta-alkylaminethyl)-dibenzo(b,f)-azepiner eller salte deraf.
DK135504B (da) Analogifremgangsmåde til fremstilling af 6-substituerede 3-carbethoxyhydrazinopyridaziner eller salte deraf.
DK125025B (da) Analogifremgangsmåde til fremstilling af 2,1,3-benzothiadiazol-forbindelser eller salte deraf.
DK132328B (da) Analogifremgangsmåde til fremstilling af 17beta-hydroxy-16,16-dimethylestr-4-en-3-on.
DK138449B (da) Fremgangsmåde til fremstilling af D(-)-penicillamin eller salte deraf.
DK134486B (da) Analogifremgangsmåde til fremstilling af 3-hydrazonomethyl-rifamycin-derivater eller 25-desacetyl- eller 16, 17, 18, 19, 28, 29-hexahydroderivater deraf.
DK131374B (da) Fremgangsmåde til fremstilling af 1,4-benzodiazepinderivater eller salte deraf.